Avista Public Acquisition Corp. II - Class A Ordinary Shares (NQ:AHPA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Nov 1, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Avista Public Acquisition Corp. II - Class A Ordinary Shares

Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday ↗

October 31, 2022

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.

Via Benzinga

OmniAb Business Combination Approved by APAC Shareholders

October 24, 2022

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗

October 28, 2022

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301.

Via Benzinga

Janssen Scores Conditional Approval For Multiple Myeloma Treatment In Pretreated Patients ↗

August 25, 2022

Via Benzinga

Ligand Announces that Janssen has Received Approval from European Commission for TECVAYLI® (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

August 24, 2022

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Ligand Reports Second Quarter 2022 Financial Results

August 08, 2022

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Ligand Reports First Quarter 2022 Financial Results

May 04, 2022

From Ligand Pharmaceuticals Incorporated

Via Business Wire

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL ↗

March 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Ligand To Spin-Off OmniAb Via Avista Capital-Backed SPAC Merger ↗

March 24, 2022

Ligand Pharmaceuticals Inc (NASDAQ: LGND)

Via Benzinga

Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II

March 23, 2022

From Ligand Pharmaceuticals Incorporated

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.